Your browser doesn't support javascript.
loading
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease.
Snyder, Katiri J; Choe, Hannah K; Gao, Yandi; Sell, Natalie E; Braunreiter, Kara M; Zitzer, Nina C; Neidemire-Colley, Lotus; Kalyan, Sonu; Dorrance, Adrienne M; Keller, Andrea; Mihaylova, Maria M; Singh, Satishkumar; Sehgal, Lalit; Bollag, Gideon; Ma, Yan; Powell, Ben; Devine, Steven M; Ranganathan, Parvathi.
Afiliação
  • Snyder KJ; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Choe HK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Gao Y; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Sell NE; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Braunreiter KM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Zitzer NC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Neidemire-Colley L; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Kalyan S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Dorrance AM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Keller A; Department of Biological Chemistry and Pharmacology, Comprehensive Cancer Center, The Ohio State University Columbus, Columbus, OH, United States.
  • Mihaylova MM; Department of Biological Chemistry and Pharmacology, Comprehensive Cancer Center, The Ohio State University Columbus, Columbus, OH, United States.
  • Singh S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Sehgal L; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Bollag G; Plexxikon Inc, South San Francisco, CA, United States.
  • Ma Y; Plexxikon Inc, South San Francisco, CA, United States.
  • Powell B; Plexxikon Inc, South San Francisco, CA, United States.
  • Devine SM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
  • Ranganathan P; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Front Oncol ; 11: 760789, 2021.
Article em En | MEDLINE | ID: mdl-34722316

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article